
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29. Operator: Good morning. And welcome to PDS Biotech’s …